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Mitochondrial dysfunctionBackground: Skeletal muscle wasting contributes to the poor functional status and quality of life of patients with
pulmonary arterial hypertension (PAH). The present study aims to characterize themolecularmechanismunder-
lying skeletal muscle wasting in experimental PAH induced by monocrotaline (MCT).
Methods:MaleWistar rats were randomly injectedwith saline solution (CONT; n=10) orMCT (MCT; 60mg/kg,
s.c.; n = 15). After 4 weeks of MCT or vehicle administration, animals were anesthetized and submitted to right
ventricular (RV) hemodynamic evaluation. Blood and gastrocnemius sampleswere collected and stored for anal-
ysis.
Results:MCT group developed PAH (70% increase in RV peak systolic pressure) RV dysfunction (increased end-
diastolic pressure and Tau), and body and muscle wasting (reduction of 20%, 16% and 30% on body weight, gas-
trocnemiusmass and ﬁber cross sectional area, respectively). Muscle atrophy was associated with a decrease in
type I MHC. Circulating (C reactive protein, myostatin and IL-1beta) and local catabolic markers (MAFbx/
atrogin-1, protease activity) were increased in MCT animals, while Akt/mTOR pathway was preserved. Mito-
chondria isolated from gastrocnemius of MCT animals showed decreased activity of ATP synthase, lower levels
of Tfam, accumulation of oxidatively modiﬁed proteins together with reduced levels of paraplegin.
Conclusions:Our data suggests an anabolic/catabolic imbalance in gastrocnemius fromMCT-induced PAH rats. Ac-
cumulation of dysfunctional mitochondria due to the inefﬁciency of protein quality control systems to eliminate
damaged proteins could also contribute to muscle atrophy in PAH.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Exercise intolerance experienced by patients with pulmonary arteri-
al hypertension (PAH) is classically attributed to poor functional status
secondary to cardiac and respiratory impairment [1,2]. Compelling
evidences suggest that PAH patients have intrinsic skeletal muscle
abnormalities [3,4], namely: i) decreased type I ﬁbers; ii) increased
anaerobic metabolism in skeletal muscles [4]; iii) muscle atrophy; and
iv) impaired contractility [5].
Understanding the molecular mechanisms underlying PAH-related
muscle cachexia is crucial for the development of effective preventivey and Cardiothoracic Surgery,
essor Hernâni Monteiro, 4200-
iques-Coelho).and/or therapeutic approaches. Increased levels of pro-inﬂammatory
cytokines such as TNF-alpha, IL-1 and IL-6 induce an anabolic/catabolic
imbalance in the skeletal muscle [6–12]. The activation of serine/threo-
nine kinase Akt (PKB) andmammalian target of rapamycin (mTOR) [13]
is compromised in the atrophic skeletal muscles in both chronic heart
failure [14] and cancer [15]. Impairment of mitochondrial quality con-
trol (PQC) system [16,17] and accumulation of dysfunctional mitochon-
dria lead to profound disorganization of skeletal muscle [18], and is
involved in cancer-induced muscle cachexia [15]. Whether these path-
ways are present in the wasting muscle in the context of PAH remains
unknown.
The main purpose of the present study was to assess the molecular
mechanisms underlying muscle wasting in an animal model of PAH in-
duced by monocrotaline (MCT). For this purpose, skeletal muscular
morphofunctional features and biochemical markers involved in the
regulation of muscle mass were evaluated.
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2.1. Animals and experimental design
Housing and experimental treatment of animals were in accordance
with the Directive 2010/63/EU. The experiments were performed in
compliance with the current national laws (DL 129/92, DL 197/96,
P1131/97).
Twenty-ﬁve male Wistar rats (age: 5 weeks; weight: 150 g; Charles
River Laboratories, Barcelona, Spain) were housed in groups of 5 rats/
cage, in a controlled environment at a room temperature of 22 °C with
inverted 12:12 h light–dark cycle, with free access to food and water.
Rats were randomly divided as follows: CONT (n = 10) injected with
saline solution or MCT (n = 15), injected subcutaneously with mono-
crotaline (MCT) (single dose of 60 mg/kg, s.c., Sigma). Four weeks
after MCT or vehicle administration, animals were weighed, submitted
to hemodynamic evaluation and then sacriﬁced under anesthesia by
the inhalation of amixture of 4% of sevoﬂuranewith oxygen. Blood sam-
ples (~2 mL) were collected from the inferior vena cava, centrifuged
for 5 min at 5000 g and an aliquot of serum was obtained and stored
at−80 °C for biochemical determination. Gastrocnemiusmuscles were
excised, weighed and divided. One piece was immediately processed
for lightmicroscopic evaluation and the remaining tissuewas separated
for MHC isoform quantiﬁcation and Western blotting analysis of the
whole muscle. The other muscle was used for mitochondrial isolation.
2.2. Hemodynamic evaluation
At days 28–29 after MCT or vehicle administration, animals were
prepared for right ventricular hemodynamic evaluation. Rats were
anesthetized by inhalation with a mixture 4% sevoﬂurane with oxygen,
intubated for mechanical ventilation (TOPO, Kent Scientiﬁc). The
right jugular vein was cannulated for ﬂuid administration (prewarmed
0.9% NaCl solution) and the heart was exposed by amedian sternotomy
and the pericardium was widely opened. RV hemodynamic function
was measured with conductance catheter (FTS-1912B-8018, Scisense).
The catheter was connected to MVP-300 conductance system through
interface cable (PCU-2000 MPVS, FC-MR-4, Scisense), coupled to
PowerLab16/30 converter (AD Instruments) and a personal computer
for data acquisitions. After complete instrumentation, the animal prep-
aration was allowed to stabilize for 15 min. Hemodynamic recordings
were made with respiration suspended at the end of expiration under
steady-state conditions. Parameters from conductance catheter were
recorded at a sampling rate of 1000 Hz and analyzed with Millar con-
ductance data acquisition and analysis software (PVAN3.5).
2.3. Blood tests
Serum albumin, total protein, cholesterol, HDL-cholesterol and tri-
glycerides were measured in duplicate on an AutoAnalyzer (PRESTIGE
24i, Cormay PZ). Serum levels of IL-1 beta were detected by a commer-
cially available ELISA kit, used according to the manufacturer's
instructions (R&D). Serum C-reactive protein (CRP) and myostatin
levels were assayed by Western blotting as described below. Serum
from each animal was assayed in triplicate.
2.4. Morphological analysis
Cubic pieces from gastrocnemiusmuscle (~2 mm3) were ﬁxed with
buffered paraformaldehyde 4% (v/v) by diffusion during 24 h and subse-
quently dehydrated with graded ethanol and included in parafﬁn
blocks. Xylene was used in the transition between dehydration and
impregnation. Serial cross sections (5 μm of thickness) of parafﬁn
blocks were cut by a microtome and mounted on silane-coated slides.
The slides were dewaxed in xylene and hydrated through graded
alcohols ﬁnishing in phosphate buffered saline solution (pH to 7.2).Deparafﬁnized sectionswere stained for hematoxylin-eosin by immers-
ing slides in Mayer's hematoxylin solution for 3–4 min followed by im-
mersion in 1% eosin solution for 7 min, dehydration with graded
alcohols through xylene, and mounted with DPX for analysis in a
photomicroscope (Zeiss Phomi 3). Photographs of gastrocnemius cross
sections of all experimental groups were digitalized and analyzed with
the NIH ImageJ (Image Processing and Analysis in Java, USA) software.
An average of 600 ± 170 ﬁbers were analyzed per group for area
quantiﬁcation.
2.5. Gastrocnemius muscle preparation for biochemical analysis
For the analysis of biochemical markers of anabolic and catabolic
pathways, muscles were homogenized at 4 °C in RIPA lysis buffer (1%
Nonidet P40, 0.5% sodium deoxycholate, 0.1% SDS in 50 mM NaCl,
20 mM Tris–HCl pH 7.6) containing phosphatase inhibitors (Sigma,
catalog numbers P0044 and P5726). Homogenates were clariﬁed by
centrifugation at 12,000 ×g for 20 min before determination of protein
concentration by the colorimetric method “RC DC protein assay”
(Bio-Rad) using bovine serum albumin (BSA) as standard. An aliquot
of whole muscle homogenate was used for zymography/nLC–MS/MS
analysis of proteases.
2.6. Analysis of myosin heavy chain (MHC) isoforms
Gastrocnemius sections were weighed and transferred to a glass ho-
mogenizer. A 1:19 ratio of 100mMphosphate buffer, pH 7.4, containing
0.02% bovine serumalbuminwas added andmuscle sectionswere thor-
oughly homogenized with tightly ﬁtted Potter-Elvehjen homogenizer
and Teﬂon pestle. Total protein concentration was spectrophotometri-
cally assayed with the colorimetric method “RC DC protein assay”
(Bio-Rad) using bovine serum albumin (BSA) as standard. MHC
isoformswere separated by gel electrophoresis following the procedure
described by Talmadge and Roy [19]. One microgram of sample from
each group studied was applied in the same gel. The stacking gel
consisted of 30% glycerol and 4% acrylamide: N,N′-methylene-bis-
acrylamide in the ratio of 50:1, 70 mM Tris (pH 6.7), 4 mM EDTA, and
0.4% sodium dodecyl sulfate (SDS). The separating gels were composed
of 30% glycerol, 8% acrylamide-bis (50:1), 0.2M Tris (pH 8.8), 0.1M gly-
cine, and 0.4% SDS. Polymerization was initiated with 0.05% N,N,N′,N′-
tetramethylethylenediamine and 0.1% ammonium persulphate. The
gels were run in a Mini-Protean system (Bio-Rad) at 4 °C. The running
conditions were 70 V (constant voltage) for 24 h. The gels were stained
with Colloidal Coomassie Blue, scanned in Molecular Imager Gel Doc
XR+ System (Bio-Rad, Hercules, CA, USA) and optical density analysis
of MHC bands was performed using QuantityOne Imaging software
(v4.6.3, Bio-Rad).
2.7. Mitochondria isolation from gastrocnemius muscle
Gastrocnemiusmuscleswere also used for the preparation of isolated
mitochondria, as previously described [20]. All the procedures were
performed on ice or below 4 °C. Brieﬂy, muscles were immediately ex-
cised and minced in ice-cold isolation medium containing 100 mM su-
crose, 0.1 mM ethylene glycol tetraacetic acid (EGTA), 50 mM Tris–
HCl, 100 mM KCl, 1 mM KH2PO4, and 0.2% bovine serum albumin
(BSA), pH 7.4. Minced blood-free tissue was rinsed and suspended in
fresh medium containing 0.2 mg/mL bacterial proteinase (Nagarse
E.C.3.4.21.62, type XXVII; Sigma, St. Louis, MO) and stirred for 2 min.
The sample was then carefully homogenized with a tightly ﬁtted Pot-
ter-Elvehjem homogenizer and a Teﬂon pestle. After homogenization,
Nagarse-free isolation medium was added to the homogenate, which
was then centrifuged at 700 ×g for 10 min. The resulting supernatant
suspension was centrifuged at 10,000 ×g for 10 min. The supernatant
was decanted, and the pellet was gently resuspended in the isolation
medium and centrifuged at 7000 ×g for 3 min. The ﬁnal pellet,
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dium containing 225 mM mannitol, 75 mM sucrose, 10 mM Tris, and
0.1 mM ethylenediaminetetraacetic acid (EDTA), pH 7.4. Protein con-
tent was determined with RD DC Protein Assay Kit (Bio-Rad, Hercules,
CA, USA) andmtDNA contentwas quantiﬁedwith QubitTMﬂuorometer
(Invitrogen, Carlsbad, CA, USA). The mitochondrial fraction was
aliquoted for zymography/nLC–MS/MS analysis of mitochondrial prote-
ases, immunoblot detection of paraplegin, Lon, ATP synthase β, mtTFA,
slot-blot of MMP-2, MMP-9, carbonyl and 3-nitrotyrosine content.2.8. ATP synthase activity
The activity of the respiratory chain complex V was measured ac-
cording to Simon et al. [21]. In brief, the phosphate produced by ATP hy-
drolysis reacts with ammonium molybdate in the presence of reducing
agents to form a blue-color complex, the intensity of which is propor-
tional to the concentration of phosphate in solution. Oligomycin was
used as an inhibitor of mitochondrial ATPase activity.Fig. 1. Hemodynamic evaluation (A to D), body weight (E), gastrocnemiusweight (F) and cross
animals. Values are presented as mean ± standard deviation. *P b 0.05 vs. CONT group.2.9. Western blotting analysis
Equivalent amounts of sample protein (wholemuscle, mitochondria
fractions or serum) from each experimental group were electropho-
resed on 12.5% or 5% SDS-PAGE (depending on the molecular weight
of the protein target to be immunodetected) as described by Laemmli
[22]. Gels were blotted onto a nitrocellulose membrane (Whatman®,
Protan®) and nonspeciﬁc binding was blocked with 5% (w/v) BSA in
TBS-T (100 mM Tris, 1.5 mM NaCl, pH 8.0 and 0.5% Tween 20).
The membrane was then incubated with primary antibody solution
(1:1000 dilution; mouse anti-ATP synthase subunit β, ab14730,
abcam; rabbit anti-mtTFA, ab47548, abcam; mouse anti-BNIP3,
ab10433, acbam; rabbit anti-Bcl-2, ab33862, abcam; rabbit anti-CRP
(C reactive protein), ab32412, abcam; rabbit anti-GDF8 (myostatin),
ab996, abcam; rabbit anti-Akt, #9272, Cell Signaling; rabbit anti-
Phospho-Akt, #4058, Cell Signaling; rabbit anti-mTOR, #2983, Cell
Signaling; rabbit anti-Phospho-mTOR, #2971, Cell Signaling; rabbit
anti-paraplegin, sc-135,026, Santa Cruz Biotechnology; rabbit anti-
LONP1, ab103809; rabbit anti-atrogin-1, #AP2041, ECM Bioscience).-sectional area (G; 500 ± 170 ﬁber/group) from control and MCT-induced PAH cachectic
Table 1
Serum concentration of albumin, total protein, total cholesterol, HDL-cholesterol, triglyc-
erides (TG) and IL-1-beta form control and MCT-induced PAH cachectic animals.
CONT MCT
Albumin (g/L) 26.22 ± 2.33 21.11 ± 4.17⁎
Total protein (g/L) 49.72 ± 4.28 42.06 ± 4.76⁎
Cholesterol (mg/dL) 25.65 ± 3.78 19.49 ± 4.00
HDL-C (mg/dL) 7.45 ± 0.95 4.85 ± 2.54⁎
TG (mg/dL) 202.95 ± 84.08 59.00 ± 34.28⁎
IL-1beta (pg/mL) 106.2 ± 5.4 122.6 ± 3.7⁎
Values are presented as mean ± standard deviation.
⁎ P b 0.05 vs. CONT group.
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and incubatedwith anti-mouse or anti-rabbit IgG peroxidase secondary
antibody (1:1000 dilution, Amersham Pharmacia Biotech). Immuno-
reactive bands were detected with enhanced chemiluminescence
reagents (ECL, Amersham Pharmacia Biotech) according to the
manufacturer's procedure and images were recorded using X-ray ﬁlms
(Kodak BioMax light ﬁlm, Sigma). The ﬁlms and the gels were scanned
in Molecular Imager Gel Doc XR+ System (Bio-Rad) and analyzed with
QuantityOne software version 4.6.3 (Bio-Rad, Hercules, CA). Protein
loading was controlled by Ponceau S staining of membranes since
there are no known proteins whose expression levels are unaltered in
wasting conditions.
2.10. Slot blot analysis
For the protein carbonyl derivate assay, a given volume (V) of the
mitochondrial fraction containing 20 μg of protein was derivatized
with 2,4-dinitrophenylhydrazine (DNPH). Brieﬂy, the sample was
mixed with 1 V of 12% sodium dodecyl sulfate, 2 V of 2 mM DNPH/
10% triﬂuoroacetic acid, followed by 30 min of incubation in the dark,
after which 1.5 V of 2 M Tris-base/18.3% of β-mercaptoethanol was
added for neutralization. After diluting the derivatized proteins in Tris
buffered saline to obtain a ﬁnal concentration of 0.001 μg/μL, a 100 μL
volume was slot-blotted into a nitrocellulose membrane.
For 3-nitrotyrosine evaluation, mitochondrial fractions were diluted
in Tris buffered saline (TBS) to obtain a ﬁnal protein concentration of
0.001 μg/μL and a volume of 100 μLwas slot-blotted into a nitrocellulose
membrane (Whatman®, Protan ®). Immunodetection was performed
as described above using rabbit anti-DNP (DakoCytomation) or anti-
nitrotyrosine (#06-284; Millipore) as primary antibodies.
For MMP-2 and MMP-9 assessment, 10 μg of whole muscle protein
was diluted in 100 μL of TBS and slot-blotted into a nitrocellulosemem-
brane. Immunodetection was performed using mouse anti-MMP-2
(clone 101721; R&D Systems) and anti-MMP-9 (clone 36020; R&D Sys-
tems). Protein loading was controlled by Ponceau S staining.Fig. 2. SerumCRP (A) andmyostatin (B) levels from control andMCT-induced PAH cachectic an
results obtained from 10 animals per group, assayed in duplicate. *P b 0.05 vs. CONT group; **P2.11. Proteolytic activity analysis by zymography
Zymography assays were performed according to Padrão et al. [15].
Brieﬂy, the zymography was performed using a 10% SDS-PAGE separa-
tion gel with 0.1% of gelatin. Fortymicrograms of sample (wholemuscle
homogenate or mitochondrial fractions) from each group was incubat-
ed on charging buffer (100 mM Tris pH 6.8, 5% SDS, 20% glycerol, 0.1%
bromophenol blue) for 10 min on ice, at a proportion of 1:1 (v/v).
After the run, gels were incubated in renaturation buffer (2.5% Triton
X-100) for 30 min, with soft agitation. Then, the zymogram gels were
changed to a development buffer (50 mM Tris, 5 mM NaCl, 10 mM
CaCl2, 1 μm ZnCl2, 0.02% (v/v) Triton X-100, pH 7.4) for more than
30min, alsowith soft agitation. Gels were then changed to a new devel-
opment buffer, and incubated overnight at 37 °C. For speciﬁc inhibition
studies zymograms were incubated in a solution containing 10 mM
EDTA or 1 mM PMSF. The zymography gels were stained with 0.12%
(w/v) Coomassie Blue G250 in 20% methanol, after 1 h ﬁxation in a so-
lution of 10% acetic acid and 40% methanol. Gels were then destained
with 25% methanol and scanned with Gel Doc XR System (Bio-Rad).
The zymography bands that showed proteolytic activity were excised
manually from the gel for nano-LC–MALDI-MS/MS, performed as previ-
ously described [23].2.12. Statistical analysis
Values are given as mean± standard deviation for all variables. The
Kolmogorov–Smirnov test was performed to check the normality of the
data. The Kruskal–Wallis test followed by Dunn's test was used for non-
normal data (cross sectional area). The statistical signiﬁcance of the dif-
ferences between the experimental groups was determined using the
unpaired Student's t-test. Results were considered signiﬁcantly differ-
ent when P b 0.05. Statistical analysis was performed with GraphPad
Prism software (version 6.0).3. Results
3.1. Evidences of PAH-related muscle wasting
Animals treated with MCT developed PAH as shown by the increase
in RV Pmax (P b 0.01; Fig. 1-A). This was paralleled by a decrease in HR
(P b 0.01; Fig. 1-B), increase in PED (P b 0.01; Fig. 1-C) and slowing of re-
laxation (P b 0.01; Fig. 1-D), suggesting development of RV dysfunction.
Signiﬁcant loss of bodyweight was observed 4weeks after MCT admin-
istration (20% reduction; P b 0.001; Fig. 1-E). This body weight decrease
was accompanied by a 16% reduction in gastrocnemiusmass (P b 0.001;
Fig. 1-F), and by a signiﬁcant decrease of CSA (P b 0.001) (Fig. 1-G).imals, assessed byWestern blotting. Values are presented asmean± standard deviation of
b 0.01 vs. CONT group.
Fig. 3.MHC distribution in gastrocnemius of control and MCT-induced PAH cachectic ani-
mals. The amount of each MHC isoform is presented as percentage of the total MHC pool
on the gel for that sample. Immediately above the histogram, a representative 8% SDS-
PAGE shows the distribution of MHC isoforms. Values are presented as mean ± standard
deviation of results obtained from 5 independent experiments. *P b 0.05 vs. CONT group.
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As depicted in Table 1 and in Fig. 2, statistically signiﬁcant alterations
of serum markers of inﬂammation and catabolic factors were observed
in MCT. This group presented a signiﬁcant decrease in serum albumin
and total protein levels, as well as HDL-cholesterol and triglycerides
(P b 0.05). These modiﬁcations were paralleled by an increase in
levels of the pro-inﬂammatory cytokine IL-1beta (P b 0.05), CRP and
myostatin (P b 0.05 and P b 0.01, respectively).
3.3. MHC isoform proﬁling of gastrocnemius muscle
Fig. 3 shows a representative 8% polyacrylamide gel evidencing the
distribution of MHC isoforms in gastrocnemius muscle from control
and MCT-treated rats. Three MHC isoforms can be observed, with pre-
dominance of type IIb MHC. A shift in MHC expression was observed
in MCT, showing a decrease of type I MHC isoform in comparison to
CONT group (P b 0.05).Fig. 4. The Akt/mTOR pathway and on MAFbx/atrogin-1 expression in gastrocnemiusmuscle
phospho-Akt and total Akt (A), phospho-mTOR and totalmTOR (B), and atrogin-1 (C) are shown
of results obtained from 10 independent experiments and are presented as arbitrary units of o3.4. Anabolic/catabolic balance in gastrocnemius muscle
To determine the effect of MCT-induced PAH on the anabolic status
of gastrocnemius muscle, Western blotting analysis of Akt and
mTOR was performed. The activation state of Akt was assessed with a
phospho-speciﬁc antibody. No differences were found in the gastrocne-
miusmuscle levels of phospho-Akt, Akt, and phospho-Akt/Akt ratio be-
tween MCT and CONT groups (Fig. 4-A and B). As depicted in Fig. 4-C
and D, no signiﬁcant differences were found on the expression of
mTOR and on its phosphorylated form at Ser2448 and phospho-Akt/Akt
ratio between MCT and CONT groups. The contribution of the
ubiquitin-proteasome system to muscle cachexia was evaluated by the
expression of MAFbx/atrogin-1 (Fig. 4-E). Our data evidences a signiﬁ-
cant overexpression of this E3 ligase (approximately 40%) in the gas-
trocnemiusmuscle of MCT rats (P b 0.05).
An overall analysis of muscle proteolysis was performed by
zymography and two bands with high proteolytic activity were found
with approximately 70 kDa (band 1) and 15 kDa (band 3) (Fig. 5). A sig-
niﬁcant increase of the proteolytic activity was observed in MCT group
(P b 0.001). MCT also induced alterations in the proteolytic proﬁle
reﬂected by the decreased activity of band 1 and the appearance of
band 2, with approximately 30 kDa. To assess the classes of proteases
that were present in each band, we incubated zymo gels with different
inhibitors at their maximum effective concentration: EDTA (metallo-
proteinase inhibitor) and PMSF (serine protease inhibitor). Data obtain-
ed (Fig. 5-C and D) suggest the involvement of both serine and
metalloproteinase proteases. In order to identify the proteases present
in each band nLC–MALDI-MS/MS was performed. No proteases could
be identiﬁed probably by the low amounts of these proteins in the
whole skeletalmuscle proteome. Nevertheless, considering themolecu-
lar weight of the bands with proteolytic activity (according to Uniprot
(http://www.uniprot.org/)) we might suspect the presence of MMP-2
(72 kDa) and MMP-7 (30 kDa). To corroborate zymography data, we
analyzed the levels of MMP-2 (Fig. 5-F) and signiﬁcantly higher levels
of this protease were observed in the gastrocnemiusmuscle from MCT
rats (P b 0.05).We alsomeasured the levels ofMMP-9, anotherMMP re-
ported to be overexpressed in wastedmuscle [15]; however, no expres-
sion differences were observed among the groups (Fig. 5-G). This data
supports zymography analysis once no bandwith activitywas observed
at 92 kDa, the molecular weight of this MMP.from control and MCT-induced PAH cachectic animals. Representative Western blots for
above the correspondent histograms. Values are presented asmean± standard deviation
ptical density. **P b 0.01 vs. CONT group.
Fig. 5.Whole gastrocnemiusmuscle proteolytic activity in control and MCT-induced PAH cachectic animals. (A) Representative image of the zymography evidencing one band with no-
ticeable proteolytic activity (band 3). An overlap of densitometric variation for all groups' lanes is presented in the right side of zymo gel (B). Representative image of the zymo gels in
the presence of inhibitors for (C) serine proteases (PMSF) and for (D) metalloproteinases (EDTA). Overall proteolytic activity in each group is presented (E). Comparative analysis of
MMP-2 (F) andMMP-9 (G) expression between groups. Values are expressed asmean± standard deviation of results from 5 animals per group. *P b 0.05 vs. CONT; ***P b 0.001 vs. CONT.
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Mitochondrial DNA (mtDNA) and protein concentration was mea-
sured in mitochondrial fractions and normalized to muscle mass
(Table 2). Higher concentration of mtDNA-to-muscle mass was ob-
served in MCT group. Mitochondria fromMCT group showed lower ex-
pression values of ATP synthase beta (Fig. 6-A) and Tfam (Fig. 6-B) and
decreased activity of ATP synthase (Fig. 6-C).
To assess the contribution of mitochondrial proteolysis to MCT-
related cachexia, zymography analysis of mitochondrial fractions was
performed. There was an overall increase of mitochondrial proteolytic
activity in the MCT group (Fig. 7). The densitometric evaluation
displayed six main bands in the zymogram of theMCT group, a number
higher than in the CONT group. One of these bands showed higher activ-
ity in both groups, with approximately 15 kDa (band 6), previously
identiﬁed as a fragment of Lon protease [23]. In MCT mitochondria,
bands 4 and 5 (with approximately 30 kDa and 20 kDa, respectively)Table 2
Mitochondrial protein content and mtDNA concentration in gastrocnemius muscle from
control and MCT-induced PAH cachectic animals.
CONT MCT
Protein/mtDNA (μg/g) 1.58 ± 0.38 0.58 ± 0.29⁎⁎⁎
mtDNA/muscle weight (μg/g) 1.42 ± 0.70 3.32 ± 0.58⁎⁎
Protein/muscle weight (mg/g) 2132.7 ± 964.5 1954.7 ± 819.6
Values are presented as mean ± standard deviation.
⁎⁎ P b 0.01 vs. CONT group.
⁎⁎⁎ P b 0.001 vs. CONT group.also showed high activity. Both serine and metalloproteases seem to
be involved inmitochondrial remodeling inMCT (Fig. 7-C and D). To as-
sess the involvement of the AAA serine proteases to mitochondrial pro-
teolysis, paraplegin and Lon expression was analyzed by Western
blotting and lower expression values were present in MCT (P b 0.05)
(Fig. 8-A and B). Considering the involvement of these proteases in
the elimination of damaged proteins, the levels of carbonylated and
nitrated mitochondrial proteins were determined and signiﬁcantly
higher values were also observed in MCT animals (P b 0.001 for
carbonylated proteins and P b 0.05 for nitrated proteins).
The contribution of mitophagy to MCT-related muscle wasting was
also evaluated through the assessment of Bnip3 and Bcl-2 levels.
Bnip3 acts as a mitophagy receptor that targets mitochondria for re-
moval by autophagosomes [24] and Bcl-2 inhibits autophagy through
a direct interactionwith the autophagy protein beclin 1 [25]. No expres-
sion differences of these proteins were observed among groups when
whole skeletal muscle tissue (data not shown) or mitochondrial frac-
tions (Fig. 8-E and F) were analyzed. These data suggest that mitophagy
is not inﬂuenced by MCT administration and has adapted to muscle
wasting.
4. Discussion
The present work provides new insights into the molecular mecha-
nisms underlying muscle wasting in PAH. Our data shows that MCT-
induced PAH results in signiﬁcant skeletal muscle loss that is accompa-
nied by an increase in circulating (IL-1beta, CRP, myostatin) and local
catabolic markers (MAFbx/atrogin-1 and protease activity), without af-
fecting Akt/mTOR pathway. The ﬁnding of higher amounts of mtDNA-
Fig. 6.Mitochondrial ATP synthase beta (A) and Tfam(B) expression determinedbyWestern blotting, andATP synthase activity (C), from control andMCT-induced PAH cachectic animals.
Values are expressed as mean ± standard deviation of results from 7 animals per group. ***P b 0.001 vs. CONT.
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expression and activity, reduced Tfam and paraplegin expression, and
no alteration in the expression of the pro- and anti-autophagy proteins
Bnip3 and Bcl-2, suggests an accumulation of dysfunctional mitochon-
dria in skeletal muscle.
MCT model is a well-established model to study the pathophysiolo-
gy of PAH because it mimics most of its pulmonary and cardiac features
[26–30]. This model also induces muscle and body mass loss [31] and
represents a good approach to study skeletal muscle wasting secondary
to PAH. After 4 weeks of MCT injection, approximately 19% of weight
loss was present, which fulﬁlls the criteria for cachexia [32]. The signif-
icantly high serum levels of the pro-inﬂammatory cytokines IL-1β and
of the acute phase protein CRP, and the lower serum levels of albumin
observed in MCT animals, support the contribution of inﬂammation to
the catabolic proﬁle noticed in this group. The higher serum levels ofFig. 7.Mitochondrial proteolytic activity of gastrocnemiusmuscle from control andMCT-induce
with noticeable proteolytic activity (bands 4, 5 and 6) (A). An overlap of densitometric variation
zymo gels in the presence of inhibitors for (C) serine proteases (PMSF) and for (D)metalloprote
the image of zymo gel (E). Values are expressed as mean ± standard deviation of results frommyostatin, an activin-related TGF-β protein, also contributed to MCT-
related catabolic phenotype, supporting its role as a negative regulator
of muscle mass [15].
In the present study, gastrocnemiusmuscle was used since glycolytic
muscles are more vulnerable to catabolic muscle cachexia [33]. This
fast-twitch muscle presented important muscle atrophy as shown by
the 16% reduction in muscle mass and 30% reduction in ﬁber cross-
sectional area (CSA). The higher differences noticed in CSA than inmus-
cle weight might be justiﬁed, at least in part, by ﬁbrosis and edema,
which directly inﬂuence the muscle mass but not the CSA. Muscle atro-
phy was accompanied by a shift in MHC isoform with a signiﬁcant de-
crease in type I MHC and an increase in type IId/x MHC, though not
statistically signiﬁcant, a pattern previously reported in skeletal muscle
cachexia secondary to cancer [34], chronic heart failure [35] and more
recently in PAH patients [4]. These modiﬁcations were previouslyd PAH cachectic animals. Representative image of the zymography evidencing three bands
for groups' lanes is presented in the right side of zymo gel (B). Representative image of the
inases (EDTA). Overall mitochondrial proteolytic activity in each group is presented below
5 animals per group. ***P b 0.001 vs. CONT.
Fig. 8.Mitochondrial paraplegin (A), Lon (B), Bcl-2 (C) and Bnip3 (D) expression and the levels of carbonylated (E) and nitrated (F)mitochondrial proteins from control andMCT-induced
PAH cachectic animals. Values are expressed as mean ± standard deviation of results from 10 animals per group. *P b 0.05 vs. CONT; ***P b 0.001 vs. CONT.
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ing velocity, maximal force and power output [34].
This study presents clear evidences of anabolism/catabolism imbal-
ance associated with MCT-induced muscle loss and decreased ﬁber
CSA. The involvement of the ubiquitin–proteasome pathway in muscle
atrophy is well established [7,35,36]. Protein ubiquitination is a highly
ordered process whereby proteins to be degraded are tagged by multi-
ple E3 ubiquitin ligases for subsequent proteolytic cleavage [10]. The
up-regulation of the muscle speciﬁc E3 ligase MAFbx/atrogin-1 ob-
served in MCT group emphasize the importance of this proteolytic
mechanism to the pathophysiology of PAH. Zymography analysis of gas-
trocnemius evidenced a signiﬁcant increase of proteolytic activity with
contribution of MMPs. The activation of MMP-2 and MMP-9 in skeletal
muscle was previously reported in atrophic conditions [37], and associ-
ated with the disruption of the connections between cells at the base-
ment membrane and of cell-to-cell interactions [38]. Data supports an
increased expression and activity of MMP-2 in PAH-related muscle
wasting, though without the participation of MMP-9, in opposition to
what happened in bladder cancer-related muscle wasting [15].
The catabolic state observed in PAHmay bemodulated, at least par-
tially, by the pro-inﬂammatory environment that characterizes these
patients [11]. Data from our study reinforce the idea that over-activity
of inﬂammatory mediators (like IL-1 beta and CRP) fuels the activity
of the ubiquitin–proteasome system [9,36] and proteases as MMPs
[39]. Pro-inﬂammatory cytokines have also been shown to be involved
in altered lipid metabolism including enhanced lipolysis [12], though
not corroborated by the low serum triglycerides levels observed inMCT animals. However, in a rat model of cancer cachexia lower levels
of triglycerides were also observed [15]. The catabolic cytokine
myostatin also seems to play a role in MCT-related muscle cachexia. Al-
though mainly expressed in skeletal muscle, it seems that during cardi-
ac overloading diseases the myocardium also produces and secretes
myostatin into the circulation that is thought to inhibit skeletal muscle
growth [6,36,40,41]. Data support that myostatin together with cyto-
kines like IL-1β elicits catabolism on skeletal muscle by elevating the
levels ofmuscle-speciﬁc E3 ligases as atrogin-1 and increasing the intra-
cellular protein degradation through the ubiquitin–proteasome path-
way [42–44].
Phosphatidylinositol 3-kinase (PI3K)/Akt signaling cascade is in-
volved in the control of protein synthesis [13] and in the modulation
of MAFbx/atrogin-1 and MuRF-1 expression [45]. Apart from its role in
hypertrophy, Akt has been described as an effector of anabolic signals
that actively prevents muscle atrophy by inhibiting muscle speciﬁc E3
ubiquitin ligases [45]. In the present study, the amount of Akt, and
more importantly the phosphorylated Akt, showed no alterations in
gastrocnemius muscle of cachectic rats. The same was observed
for mTOR, one important target of Akt [46]. Our data suggest that Akt/
mTOR pathway is not correlated with muscle wasting in MCT-induced
cardiac cachexia. While similar observations were made in chronic
obstructive pulmonary hypertension [10], less clear results were
reported in cancer-induced muscle wasting settings [9,13,47]. Possibly,
disturbances of the Akt/mTOR pathway may be time- and cancer
type-dependent and manifest as the severity of the disease progresses.
Therefore, muscle hypercatabolic response through the ubiquitin–
2730 D. Moreira-Gonçalves et al. / Biochimica et Biophysica Acta 1852 (2015) 2722–2731proteasome pathway and MMP activity seems to be the major molecu-
lar feature underlying muscle wasting in MCT-induced PAH.
Mitochondria are recognized as the principle drivers of ATP genera-
tion and could be the place of energy wasting in situations of highmus-
cle proteolysis. In accord with previous ﬁndings [15,48], this study
suggests an accumulation ofmitochondriawith lower ability to produce
ATP not counteracted by mitophagy, and an impairment in mitochon-
dria transcription, as we observed decreased activity of ATP synthase
and lower levels of the transcriptional factor Tfam with no alterations
in Bnip3 content in gastrocnemius muscles of MCT animals. Our data
also highlight the accumulation of oxidatively modiﬁed proteins, either
carbonylated or nitrated, thatwere not cleared out fromMCTmitochon-
dria by the PQC systems, which include the AAA protease paraplegin
and thematrix protease Lon that were present in lower levels in themi-
tochondria from MCT gastrocnemius. Despite the higher proteolytic ac-
tivity noticed in the gastrocnemius from MCT-treated animals,
mitochondrial PQC systems were not effective in removing damaged
proteins. Thus, accumulation of damaged and bioenergetically inefﬁ-
cient organelles not cleared out by mitophagy can have a deleterious
impact on myoﬁber health since they can release pro-apoptotic factors
and reactive oxygen species that contribute to muscle loss [18].5. Conclusion
The current study provides molecular insights into the mechanisms
underlying PAH-related muscle wasting. A clear anabolism/catabolism
imbalance evidenced by circulating and local markers of proteolysis
was noted in MCT gastrocnemius. Accumulation of dysfunctional mito-
chondria due to the inefﬁciency of PQC system to eliminate damaged
proteins could also contribute to muscle atrophy. Although PAH is ini-
tially a pulmonary vasculopathy, important cross-talk among lungs,
heart, and skeletal muscle might contribute to the poor functional ca-
pacity and quality of life of patients with PAH.Funding
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